Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 36,470 shares at $40.34 ($1.5M) on 2024-03-21, disclosed to the SEC on 2024-03-22.
Open-market sale of $1.5M RYTM by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.34 | 18,235 | $736K | 50.0% |
| 2 | $40.34 | 18,235 | $736K | 50.0% |
| Total | $40.34 avg | 36,470 | $1.5M | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |